|
|
Nutrition status of patients with esophageal cancer and its management |
1 QI Shu-jing, 1 QI Rui-xia, 2 ZHANG Wu-lin, |
|
|
Abstract Esophageal cancer is one of the most common malignant tumors in China. The morbidity and mortality of malignant tumors in China are the 5th and 4th places respectively, and they are increasing year by year. Nutritional support plays an important role in patients with esophageal cancer. Due to factors such as obstruction, difficulty in swallowing, tumor consumption, esophageal cancer patients can easily lead to insufficient intake of protein, fat, carbohydrate, vitamins and minerals and fluid, and thus cause
malnutrition situation even worse. Malnutrition increases the incidence of postoperative complications, which affects postoperative
rehabilitation and follow-up treatment. The proper use of nutritional support is an important component of surgeons and medical oncologists. Oncologists should be aware that patients with esophageal cancer are at high risk for complications related to malnutrition. While overweight and obesity clearly increase the risk of surgical complications, weight loss is not only associated with
the risks of surgery, but also with chemotherapy, radiotherapy and comprehensive treatment compliance. This eventually turns out
to be lower recovery rates and cure rates. Oral nutrition supplement is a simple procedure which needs work closely with nutrition experts. Tube feeding, with the use of commercial formulations, provides adequate macro and trace elements for patients who are not suitable for oral nutrition supplements. In the context of perioperative nutritional support, PEG should be limited because it has been
widely used in various fields, especially in gastrointestinal tumors. Full use of EN or PN can reduce the incidence of complications and can shorten hospital stay.
|
|
|
|
|
[1] |
1FAN Yue-ping, 2ZHANG Tian, 2QU Qian-nuo, 3SHI Han-ping. Interpretation of expert consensus for nutritional therapy pathway of malignant tumor in China—peripheral venous catheterization[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 301-304. |
[2] |
ZHAO Xiang,WANG Wen-jing. ONS improves nutritional status of esophageal cancer patients under radiotherapy treatment[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 357-360. |
[3] |
1XUE Tao, 1WANG Wei-hong, 2MA Hui,1ZHANG Na,1ZHANG Sheng-Jun, 1DU Xin-ying . Application of perioperative nutritional support in patients with meningioma[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 326-331. |
[4] |
CHENG Guo-wei, SUN Li, CHEN Ping, HE Xiang-ling, SU Dan, XI Heng-zhi, ZANG Ding-qi. Nasojejunal nutrition therapy improves the efficacy and decreased adverse reactions of radiotherapy for esophageal cancer patients[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 332-336. |
[5] |
1*LUO Min, 2*WU Xiao-jun, 2ZHANG Xin, 3DONG Guang, 4XIONG Li-long, 4WANG Peng-cheng, 1GAO Kui, 1YU Ping, 1HE Mei, 5DU Chi, 5JIANG Ou, 6SHI Han-ping . ABD bioactives alleviates chemotherapy-induced myelosuppression[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 346-350. |
[6] |
1,2GENG Bi-zhu, 1ZHENG Jin. Review of family nutrition support research during the intermission of chemotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 386-390. |
|
|
|
|